19 March 2010 - Dr Rabinder Buttar, President & CEO of Global CRO (Contract Research Organisation), ClinTec International, became the only female director this year to pick up a Regional Director’s Award at the renowned Institute of Directors (IOD), Director of the Year Awards.
Dr Buttar picked up the Regional Award for Glasgow & West of Scotland during the exclusive event held at Edinburgh’s Grand Sheraton Hotel and attended by over 300 guests. Kaye Adams, journalist and former lead presenter of Loose Women, and John Swinney, MSP for North Tayside and Cabinet Secretary for Finance and Sustainable Growth in the Scottish Government, presented the prestigious awards ceremony.
The IOD Awards celebrate the successes of Scotland’s business leaders and acknowledge the vision and courage the directors have shown in 2009 to drive their organisations forward in a challenging climate.
Dr Buttar was overjoyed to reach the finals for two awards: Global Business Director of the Year and West of Scotland Regional Director. On receiving the award, Dr Buttar commented: “I am truly honoured to become the IoD’s Director of the Year for Glasgow & West of Scotland. I would like to accept this award on behalf of ClinTec’s Glasgow HQ and global teams, who have been essential in helping ClinTec get to where it is today. 2009 was our most successful year yet, which I believe is all down to my staff’s loyalty and can-do attitude, supporting our clients’ needs in the every way possible. My thanks also go to all our business and co-operation partners in the West of Scotland who have been truly excellent in supporting us through this immense period of growth.
Dr Buttar launched ClinTec International in 1997 from her home in Germany where she was living at the time. With its fast and flexible approach to drugs development, ClinTec International is now present in 40 countries and has rapidly become an established brand supporting some of the foremost names in the pharmaceuticals and biotech industry.
In 2009, the company expanded into 17 new countries, employed 115 new staff across the globe, signed contracts with 11 of the top 25 pharmaceutical companies, and has reported its best financial results ever.
ClinTec International excels at breaking into and developing expertise in emerging markets. The company has a reputation for recruiting, training and developing new talent pools wherever the organisation operates, and later this year will be launching a Global Academy of Clinical Excellence.
About ClinTec International
ClinTec International is a full service global clinical research organization, which was founded in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec International has a presence in more than 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, Middle East and North Africa, Central and South Africa, Latin America, India and the US. In addition to ClinTec’ vast expertise in oncology, it has also conducted over a 150 clinical trials in many other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers, country managers and clinical research associates. ClinTec International’s ‘fast, flexible and focused’ approach to clinical research ensures an added advantage to the drug development process. ClinTec International provides clinical research resourcing services for the conduct of phase I – IV clinical trials worldwide.
